Erasca, Inc.

ERAS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Nov 14, 2024 ARCH VENTURE FUND X, L.P. - ERASCA, INC. -- SCH 13G/A(#1E)
SC 13G/A Nov 14, 2024
SC 13G Nov 14, 2024
10-Q Nov 12, 2024 10-Q
8-K Nov 12, 2024 8-K
SC 13G Nov 8, 2024
SC 13G/A Oct 29, 2024 SC 13G/A
SC 13G Oct 24, 2024
8-K Oct 24, 2024 8-K
144 Oct 15, 2024
144 Sep 16, 2024
144 Aug 15, 2024
10-Q Aug 12, 2024 10-Q
8-K Aug 12, 2024 8-K
144 Jul 15, 2024
8-K Jun 24, 2024 8-K
8-K Jun 24, 2024 8-K
4 Jun 21, 2024 FORM 4 SUBMISSION
4 Jun 21, 2024 FORM 4 SUBMISSION
4 Jun 21, 2024 FORM 4 SUBMISSION
4 Jun 21, 2024 FORM 4 SUBMISSION
4 Jun 21, 2024 FORM 4 SUBMISSION
4 Jun 21, 2024 FORM 4 SUBMISSION
4 Jun 21, 2024 FORM 4 SUBMISSION
4 Jun 21, 2024 FORM 4 SUBMISSION
← Newer Page 6 of 14 · 350 filings Older →